Mary Harney BSc BA MAICD FIML
Throughout a cross sectoral career, one of my many strengths has proven to be the ability to connect innovative ideas and people.
Mary is the director of specialist consulting firm - Mary Harney Advisory - providing leadership, governance & strategic advice across innovation industries such as health, biotech & agriculture.
An accomplished Chairman, NED and Chief Executive with decades of experience, currently serving as the Chair of three health related companies; ASX listed, Race Oncology (ASX:RAC), private med-tech company, Microbio Ltd and the Australian Biotechnology Company, Oncology One.
My belief is the singular responsibility of our generation is to feed, fuel and heal the planet.
A successful executive who loves ideas & outcomes
Mary has experience across all aspects of the health sector, benchmarked internationally. She is a business builder & convergence specialist.
An influential public speaker, she was awarded an Honorary Member of the Global Surgery & Social Charge Division of Harvard Medical School.
In 2016 Mary was the recipient of the Monash University "Science Alumni of the Year". Mary was also invited by the Science & Medical Faculty to be the Monash University Graduation Speaker in 2017.
Credentials
Strategy in the Age of Digital Disruption: INSEAD Business School
BA (Fine Arts) University of Melbourne
AICD: Member
BSc Monash University
Fellow of Institute of Manangement & Leaders
International Academy of Cytology
Board & Industry Highlights
Chairman Race Oncology (ASX:RAC)
Race Oncology is an ASX-listed precision oncology company with a Phase ll/lll small molecule cancer drug called Bisantrene.
Chairman Oncology One Pty Ltd
Oncology One is implementing a strategy focused on building a diversified pipeline and aims to help translate more of Australia's cancer research into treatments.
Chairman Microbio Limited.
An Australian biotechnology company, which aims to revolutionise pathogen detection with a unique, specific, sensitive and rapid, pathogen identification test. The novel diagnostic method combines the latest advances in bioinformatics, genomic and molecular microbiology and will be first marketed for rapid sepsis detection. Sepsis is a WHO defined global heath priority.
Interim CEO Breakthrough Victoria Investment Fund
The $2billion Breakthrough Victoria Fund will drive investment in translational research and commercialisation outcomes to accelerate growth in key industry sectors and create jobs.
CEO Royal Australian College of Surgeons: Director Foundation for Surgery
CEO Gardiner Research Foundation: Company Secretary
COO Peter MacCallum Hospital: Director of Office of Clinical Research
COO Cerylid Biosciences: Company Secretary
Awards
B-HERT Award "Excellence in Collaboration" - Industry & Academia
(Dairy Industry & Monash University)
Speaking Engagements
Harvard Medical School Surgery & Social Change
Five billion people worldwide do not have access to safe and affordable surgery. ANZ surgeons, with DFAT, play a leading role in training the next generation of surgeons to address this need in the Pacific Region – providing a role model for others in Global Health.
Royal Australasian College of Surgery
Integrity and standards of leaderships & professionalism.
VESKI
The conundrum ‘can we feed the planet without destroying it?'
Monash University School of Science & Medicine - Graduation Key Note 2017
Keep a balance between healthy wise ambition and respectful followership. Learn how to recognise the difference while being optimistic, curious and courteous. (View Here)
Australian Orthopaedics Association
"Doubt is an uncomfortable position. But certainty is an absurd one” . Invisible leadership as an influencer for modern surgeons.
Royal Australian Chemistry Institute
Bananas and Sacred Cows – a contrarian view of ‘everything.’
AUSTRADE
An overview of Australia’s Rural Research & Development Corporations (RDC) - a unique government and primary producer agreement to co invest in research and development to drive agricultural innovation.
International Acadamy of Cytology
Invited Plenary: Diagnosis of Central Nervous System Tumours via stereotaxic biopsy.
Mary is available for
Speaking Engagements
Blog
